Auckland, New Zealand, Dec. 09, 2025 (GLOBE NEWSWIRE) -- ACES Pest Control, an Auckland-based provider of science-driven pest-management solutions, announced the company-wide deployment of Meta Smart Glasses developed by Meta Platforms Inc. for its field technicians. "A New Way for Customers to See Infestations in Their Home or Business" The wearable, hands-free imaging technology enables precise photo and video capture from previously inaccessible areas, offering property owners across Auckland and throug ...

Core Insights - Orkin Canada has released its annual "Rattiest Cities" list for 2025, with Toronto maintaining its position as the top city for rodent issues in Canada [1][2] - The rankings are based on the number of rodent treatments conducted by Orkin Canada from August 1, 2024, to July 31, 2025 [2] - The top 10 rattiest cities include Toronto, Victoria, Vancouver, Burnaby, Richmond, Mississauga, Kelowna, Ottawa, Scarborough, and Moncton [4] Company Overview - Orkin Canada is a subsidiary of Rollins, Inc. and is recognized as Canada's largest pest control and environmental services provider [3] - The company offers a Home Pest Protection Program that provides customized pest control and prevention services to ensure a pest-free environment for homeowners and property owners [3] - Orkin Canada serves both residential and commercial clients across the country [3] Rodent Prevention Tips - Recommendations for rodent prevention include trimming trees and shrubs to eliminate hiding spots, fixing leaks to remove water sources, and regularly inspecting for signs of rodent activity [4] - It is advised to seal entry points larger than 1/4 inch and maintain cleanliness by storing food in sealed containers and cleaning up spills immediately [4]

Core Viewpoint - Rollins reported strong Q3 2025 earnings, with both earnings and revenues exceeding estimates, indicating a positive demand environment for its services [2][3]. Financial Performance - Adjusted earnings were 35 cents per share, surpassing the consensus estimate by 9.4% and reflecting a year-over-year increase of 20.7% [3]. - Revenues reached $1 billion, slightly beating the consensus mark and showing a 12% year-over-year improvement [3]. - Organic revenues amounted to $982.1 million, marking a 7.2% increase year over year [3]. Segment Performance - Residential revenues grew by 11.2% year over year to $476.3 million, exceeding estimates [4]. - Commercial revenues increased by 11.8% year over year to $335 million, also surpassing estimates [4]. - Termite and ancillary revenues rose by 15.2% year over year to $204.7 million, though this fell short of estimates [4]. Profitability Metrics - Adjusted EBITDA was $258.3 million, a 17.7% increase year over year, exceeding expectations [5]. - Adjusted EBITDA margin improved to 25.2%, up 120 basis points year over year [5]. Cash Flow and Financial Position - Cash and cash equivalents at the end of the quarter were $127.4 million, up from $123 million in the prior quarter [6]. - Long-term debt slightly increased to $485.7 million [6]. - The company generated $175.1 million in cash from operating activities, with free cash flow at $168 million [6]. - Dividends paid during the quarter totaled $79 million [6]. Market Sentiment and Outlook - There has been an upward trend in estimates revisions for Rollins, indicating positive market sentiment [7]. - Rollins holds a Zacks Rank 2 (Buy), suggesting expectations for above-average returns in the coming months [9].

Core Viewpoint - Rollins (ROL) has received an upgrade to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on the Zacks Consensus Estimate, which reflects EPS estimates from sell-side analysts for the current and following years [1][2]. - Changes in a company's future earnings potential, as indicated by earnings estimate revisions, are strongly correlated with near-term stock price movements [4][6]. - For Rollins, the rising earnings estimates and the rating upgrade indicate an improvement in the company's underlying business, which is expected to positively influence its stock price [5][10]. Zacks Rank System - The Zacks Rank stock-rating system classifies stocks into five groups based on four factors related to earnings estimates, with a strong historical performance of Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [7][9]. - The upgrade of Rollins to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [10]. Earnings Estimate Revisions for Rollins - For the fiscal year ending December 2025, Rollins is expected to earn $1.14 per share, which remains unchanged from the previous year, while the Zacks Consensus Estimate has increased by 2.7% over the past three months [8].

Core Insights - Orkin Canada has launched a K9 rodent detection service using a specially trained rescue dog named Puzzle to locate live rodent activity with high accuracy [1][2] - The service addresses the rising rodent populations in Metro Vancouver due to urban development and milder winters, emphasizing the importance of early detection [2][3] - The introduction of this service reflects Orkin Canada's commitment to innovation, animal welfare, and environmental responsibility [3] Company Overview - Orkin Canada is a subsidiary of Rollins, Inc. and is the largest pest control and environmental services provider in Canada [5] - The company offers customized pest control solutions through its Home Pest Protection Program, serving both residential and commercial clients [5] Service Details - The K9 service allows for detection in hard-to-reach areas, providing an eco-friendly and effective solution for property owners [2][3] - The trained dog can quickly and precisely identify live rodent activity, helping clients address issues before they escalate into larger infestations [3]

Core Insights - SenesTech, Inc. has appointed Sarah Mann and the Belize Raptor Center as the new international distributor for Evolve® Rat Birth Control, aimed at managing rodent populations in Belize [1][2] - The introduction of Evolve Rat in Belize is a response to the ecological threats posed by unregulated rodenticides, which have led to secondary wildlife poisonings [2][3] - A grassroots education campaign has been launched to inform the public about the dangers of traditional rodenticides and promote fertility control as a humane alternative [3][4] Company Overview - SenesTech is focused on creating healthier environments through humane management of animal pest populations via fertility control, with Evolve Rat Birth Control being a key product [6] - The company aims to enhance pest management programs while reducing reliance on traditional poisons, contributing to cleaner cities and healthier communities [6] Market Context - Belize's biodiversity is under threat from the increased use of rodenticides, prompting the need for sustainable solutions like Evolve Rat Birth Control [2][4] - The partnership with local conservationists reflects a growing trend of adopting fertility control methods in integrated pest management programs globally [4]

Financial Data and Key Metrics Changes - The company reported record quarterly revenues of $690,000, representing a 43% increase year-over-year and a 10% increase sequentially [17] - Gross margins remained strong at 63%, with gross profit increasing to $433,000 from $315,000 [19] - Adjusted EBITDA loss was the best in the company's history at $1.2 million, compared to $1.4 million in the previous year [7][20] Business Line Data and Key Metrics Changes - Evolved revenue increased by 77% and accounted for 85% of total sales in Q3 [17] - E-commerce sales represented 54% of total revenue, up 55% year-over-year [17][18] - Municipal revenue grew 139% year-over-year, driven by deployments in major cities [11][18] Market Data and Key Metrics Changes - Retail sales surged by 254% year-over-year, primarily due to expanded adoption through Ace Hardware and Bradley Caldwell [11][18] - Pest management professionals (PMP) accounted for 19% of sales, up 29% year-over-year and 72% sequentially [18][14] Company Strategy and Development Direction - The company aims to achieve profitability through high-margin revenue growth and efficient expense management [6][8] - Expansion into brick-and-mortar retail is being pursued, with discussions ongoing for test deployments in Lowe's stores [24] - The company is focusing on increasing production capacity and operational efficiency to meet future demand [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the cash position of over $10 million, indicating a potential path to profitability without further equity offerings [8][20] - The adoption of the evolved rodent birth control solution is seen as a game-changer, with a large addressable market and regulatory tailwinds [22] Other Important Information - The company faced legal challenges from Levitech regarding alleged IP infringement, which management described as baseless [34] - Recent field trials in Somerville and Cambridge are progressing well, with expectations for future orders based on positive results [35] Q&A Session Summary Question: Will the company's products be available in Lowe's brick-and-mortar stores? - The company is in discussions for a test deployment in about 100 stores, with expectations for late Q2 [24] Question: What growth is expected from PMP-driven sales? - PMP is a key growth channel, with significant growth anticipated as awareness of birth control in pest management increases [25] Question: How much of the revenue was from e-commerce? - E-commerce accounted for 54% of quarterly revenue, consistent with previous quarters [26] Question: Is there a plan to adjust pricing for Evolve? - The company is comfortable with the current pricing strategy but may consider discounts for large orders in the future [27] Question: What is the progress in international markets? - The company received approval for distribution in New Zealand and is working on obtaining approvals in other countries [29][30] Question: Can you provide details on the legal expenses? - The company is facing a lawsuit from Levitech, which management believes is an attempt to hinder their business [34] Question: What revenue is expected from recent field trials? - It is too early to project revenues, but positive results from trials are expected to lead to future orders [35]

A pair of Rollins shareholders are offering to sell $1 billion of the pest control company’s stock in a share sale https://t.co/foxXe7IQXb ...

Core Viewpoint - Rollins, Inc. has announced a proposed secondary public offering of $1.0 billion of its common stock by existing stockholders LOR, Inc. and Rollins Holding Company, Inc. [1][2] Offering Details - The underwriter has a 30-day option to purchase an additional $150 million of shares from the Selling Stockholders [2] - Rollins will not sell any shares and will not receive any proceeds from the offering [2] - Each Selling Stockholder is expected to enter into a 365-day lock-up agreement from the pricing date of the offering [3] Share Repurchase - The company intends to repurchase approximately $200 million of the shares being offered at the same per share price paid by the underwriter [4] - The completion of the share repurchase is conditioned on the closing of the offering [4] Underwriter Information - Morgan Stanley is acting as the sole bookrunner for the offering [5] Regulatory Compliance - The offering is made pursuant to a shelf registration statement on Form S-3 previously filed with the SEC [6] - A preliminary prospectus supplement will be filed with the SEC, and copies can be obtained from the SEC or Morgan Stanley [6]

Core Insights - SenesTech, Inc. reported a 43% increase in revenues to $690,000 for Q3 2025, marking a record for the company, with Evolve® Rodent Birth Control product sales growing 77% year-over-year, now accounting for 85% of total revenue [7][4][1] Financial Highlights - Revenues increased to $690,000 from $482,000 in Q3 2024, representing a 43% growth [7] - Gross profit margin was reported at 62.8% [7] - Net loss for Q3 2025 was $1.3 million, an improvement from a loss of $1.5 million in Q3 2024 [7] - Adjusted EBITDA loss improved to $1.2 million, compared to $1.4 million in the same quarter of the prior year [7] - Cash and short-term investments totaled $10.2 million, providing a solid operating runway [7] Operational and Strategic Highlights - Evolve Rat and Evolve Mouse products, launched in 2024, grew 77% year-over-year and are the largest revenue drivers, representing 85% of total revenue [7] - E-commerce revenue increased by 55% year-over-year, with significant growth in Amazon sales [7] - Municipal revenue grew 139% year-over-year, driven by expanded deployments in cities like New York and Chicago [7] - Retail revenue surged 254% year-over-year, largely due to increased adoption by Ace Hardware and follow-on orders from Bradley Caldwell [7] - Revenue from pest management professionals increased by 29% year-over-year, contributing nearly 20% of overall revenue for Q3 2025 [7]